Lindbrook Capital’s ProQR Therapeutics PRQR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-2,135
| Closed | -$5.66K | – | 2908 |
|
2024
Q4 | $5.66K | Buy |
+2,135
| New | +$5.66K | ﹤0.01% | 1929 |
|
2022
Q1 | – | Sell |
-2,025
| Closed | -$16K | – | 2596 |
|
2021
Q4 | $16K | Sell |
2,025
-14,311
| -88% | -$113K | ﹤0.01% | 1106 |
|
2021
Q3 | $137K | Buy |
16,336
+3,736
| +30% | +$31.3K | 0.04% | 216 |
|
2021
Q2 | $85K | Buy |
12,600
+3,000
| +31% | +$20.2K | 0.02% | 326 |
|
2021
Q1 | $63K | Buy |
9,600
+9,000
| +1,500% | +$59.1K | 0.01% | 369 |
|
2020
Q4 | $3K | Hold |
600
| – | – | ﹤0.01% | 1365 |
|
2020
Q3 | $3K | Sell |
600
-682
| -53% | -$3.41K | ﹤0.01% | 1300 |
|
2020
Q2 | $8K | Buy |
1,282
+445
| +53% | +$2.78K | ﹤0.01% | 919 |
|
2020
Q1 | $5K | Sell |
837
-563
| -40% | -$3.36K | ﹤0.01% | 1010 |
|
2019
Q4 | $14K | Buy |
1,400
+800
| +133% | +$8K | ﹤0.01% | 835 |
|
2019
Q3 | $3K | Buy |
600
+300
| +100% | +$1.5K | ﹤0.01% | 1201 |
|
2019
Q2 | $2K | Hold |
300
| – | – | ﹤0.01% | 1258 |
|
2019
Q1 | $4K | Sell |
300
-1,300
| -81% | -$17.3K | ﹤0.01% | 1128 |
|
2018
Q4 | $25K | Buy |
+1,600
| New | +$25K | 0.01% | 537 |
|